122 related articles for article (PubMed ID: 1420739)
1. Omeprazole versus famotidine in the short-term treatment of duodenal ulcer disease.
Delle Fave G; Annibale B; Franceschi M; Quatrini M; Cassetta MR; Torsoli A
Aliment Pharmacol Ther; 1992 Aug; 6(4):469-78. PubMed ID: 1420739
[TBL] [Abstract][Full Text] [Related]
2. Lansoprazole versus famotidine: efficacy and tolerance in the acute management of duodenal ulceration.
Hotz J; Kleinert R; Grymbowski T; Hennig U; Schwarz JA
Aliment Pharmacol Ther; 1992 Feb; 6(1):87-95. PubMed ID: 1543819
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole versus famotidine in the healing and relapse of duodenal ulcer.
Misra SC; Dasarathy S; Sharma MP
Aliment Pharmacol Ther; 1993 Aug; 7(4):443-9. PubMed ID: 8218758
[TBL] [Abstract][Full Text] [Related]
4. [Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Maculotti L; Pradella P
Minerva Chir; 1995 Mar; 50(3):279-81. PubMed ID: 7659265
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of omeprazole and famotidine in the treatment of duodenal ulcer.
Kumar TR; Naidu MU; Shobha JC; Reddy DN; Subhash S; Chaubal C; Prasad R; Babu S
Indian J Gastroenterol; 1992 Apr; 11(2):73-5. PubMed ID: 1428035
[TBL] [Abstract][Full Text] [Related]
6. A multicentre, randomized, double-blind study comparing nocte famotidine or ranitidine for the treatment of active duodenal ulceration.
Alcalá Santaella R; Guardia J; Pajares J; Piqué J; Pita L; Alvárez E; Castellanos P; Guarner L; Ortiz J; Pesquera R
Aliment Pharmacol Ther; 1989 Feb; 3(1):103-10. PubMed ID: 2491454
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Poynard T; Lemaire M; Agostini H
Eur J Gastroenterol Hepatol; 1995 Jul; 7(7):661-5. PubMed ID: 8590162
[TBL] [Abstract][Full Text] [Related]
8. Comparison of rabeprazole 20 mg versus omeprazole 20 mg in the treatment of active duodenal ulcer: a European multicentre study.
Dekkers CP; Beker JA; Thjodleifsson B; Gabryelewicz A; Bell NE; Humphries TJ
Aliment Pharmacol Ther; 1999 Feb; 13(2):179-86. PubMed ID: 10102948
[TBL] [Abstract][Full Text] [Related]
9. Candida overgrowth after treatment of duodenal ulcer. A comparison of cimetidine, famotidine, and omeprazole.
Goenka MK; Kochhar R; Chakrabarti A; Kumar A; Gupta O; Talwar P; Mehta SK
J Clin Gastroenterol; 1996 Jul; 23(1):7-10. PubMed ID: 8835890
[TBL] [Abstract][Full Text] [Related]
10. A controlled study of 20 mg famotidine nocte vs. 150 mg ranitidine nocte for the prevention of duodenal ulcer relapse.
Bianchi Porro G; Lazzaroni M; Barbara L; Corinaldesi R; Blasi A; Mangiameli A; Capurso L; Koch M; Cheli R; Bovero E
Aliment Pharmacol Ther; 1991 Apr; 5(2):181-9. PubMed ID: 1888818
[TBL] [Abstract][Full Text] [Related]
11. [Double-blind controlled-clinical trials of lansoprazole in the treatment of peptic ulcer].
Ogawa N
Nihon Rinsho; 1992 Jan; 50(1):68-73. PubMed ID: 1347332
[TBL] [Abstract][Full Text] [Related]
12. Symptom relief and duodenal ulcer healing with omeprazole or cimetidine. Opus (Omeprazole Peptic Ulcer Study) Research Group.
Crowe JP; Wilkinson SP; Bate CM; Willoughby CP; Peers EM; Richardson PD
Aliment Pharmacol Ther; 1989 Feb; 3(1):83-91. PubMed ID: 2491460
[TBL] [Abstract][Full Text] [Related]
13. Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.d.) in duodenal ulcer healing and pain relief.
Mulder CJ; Tijtgat GN; Cluysenaer OJ; Nicolai JJ; Meyer WW; Hazenberg BP; Vogten AJ; Gerrits C; Stuifbergen WH
Aliment Pharmacol Ther; 1989 Oct; 3(5):445-51. PubMed ID: 2518857
[TBL] [Abstract][Full Text] [Related]
14. Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: an Italian multicenter study.
Barbara L; Blasi A; Cheli R; Corinaldesi R; Dobrilla G; Francavilla A; Rinetti M; Vezzaldini P; Abbiati R; Gradnik R
Hepatogastroenterology; 1987 Oct; 34(5):229-32. PubMed ID: 3315923
[TBL] [Abstract][Full Text] [Related]
15. Single night-time doses of 40 mg famotidine or 800 mg cimetidine in the treatment of duodenal ulcer.
Lee FI; Booth SN; Cochran KM; Crowe J; Dickinson RJ; Kennedy NP; Cottrell J; Mann SG
Aliment Pharmacol Ther; 1989 Oct; 3(5):505-12. PubMed ID: 2518864
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of pantoprazole and omeprazole for the treatment of acute duodenal ulcer.
Beker JA; Bianchi Porro G; Bigard MA; Delle Fave G; Devis G; Gouerou H; Maier C
Eur J Gastroenterol Hepatol; 1995 May; 7(5):407-10. PubMed ID: 7614102
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of lansoprazole (30 mg) and omeprazole (20 mg) in the treatment of duodenal ulcer. A multicenter double-blind comparative trial].
Petite JP; Slama JL; Licht H; Lemerez M; Coste T; Andrieu J; Grimaud JC; Julien H; Dupuis J; Sallerin V
Gastroenterol Clin Biol; 1993; 17(5):334-40. PubMed ID: 8349067
[TBL] [Abstract][Full Text] [Related]
18. Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind comparative trial.
Lauritsen K; Andersen BN; Laursen LS; Hansen J; Havelund T; Eriksen J; Rehfeld JF; Kjaergaard J; Rask-Madsen J
Gastroenterology; 1991 Mar; 100(3):663-9. PubMed ID: 1993488
[TBL] [Abstract][Full Text] [Related]
19. Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide.
Reynolds JC
Clin Ther; 1988; 10(4):436-49. PubMed ID: 3079011
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic versus maintenance therapy in the prevention of duodenal ulcer recurrence. Results of a multicentric double-blind randomized trial.
Sobhani I; Chastang C; De Korwin JD; Lamouliatte H; Mégraud F; Guerre J; Elouaer-Blanc L
Gastroenterol Clin Biol; 1995 Mar; 19(3):252-8. PubMed ID: 7781936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
